Covid-19 crisis disrupted launch plans With the Covid-19 pandemic, and access restrictions to clinics and health care professionals, most...

After BioNTech SE and Pfizer, Moderna and NIH, 3rd mRNA Covid vaccine player CureVac now partners with fellow German company Bayer...

Oxford University/AstraZeneca Covid-19 vaccine, based on viral vector technology and now approved by UK authorities, will be vital for...

With COVID-19 vaccine authorization, BioNTech SE and Pfizer open the door for massive acceleration of mRNA innovation, in...

Following Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...

Use of telehealth has exploded during Covid 19 outbreak. Pharma and Medtech are considering it for launch preparation and execution....

Complex logistics ahead for Pfizer and BioNTech vaccine Complex logistics ahead for Pfizer and BioNTech will have to deal with complex...